Alpharetta, GACIK 18488094 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
45 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 100.8K | $29.70M | 17.3% | −32.0K | Reduced |
| 2 | Cidara Therapeutics Inc | 108.4K | $23.95M | 13.9% | 0 | Held |
| 3 | Protara Therapeutics Inc | 2.83M | $15.11M | 8.8% | +695.7K | Added |
| 4 |
| 8.75M |
| $11.38M |
| 6.6% |
| 0 |
| Held |
| 5 | Maplight Therapeutics Inc | 522.3K | $9.17M | 5.3% | +522.3K | New |
| 6 | Abivax SA | 67.0K | $9.04M | 5.3% | +2.6K | Added |
| 7 | Evommune Inc | 506.8K | $8.68M | 5.0% | +506.8K | New |
| 8 | Mineralys Therapeutics Inc | 151.0K | $5.48M | 3.2% | −24.6K | Reduced |
| 9 | Lantheus Hldgs Inc | 74.7K | $4.97M | 2.9% | +1.1K | Added |
| 10 | Jasper Therapeutics Inc | 2.67M | $4.88M | 2.8% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio